Home of InterVac   International Vaccine Centre

What VIDO-InterVac does best

Research excellence

• VIDO-InterVac is a world leader in developing vaccines and technologies against infectious diseases.

• Created in 1975, research collaborations have resulted in 80-plus U.S. patents and eight commercialized vaccines.  Six of these vaccines were world firsts. 

Protecting animals, Saving Lives

• Our vaccines have saved millions of dollars for the agricultural industry, making Canada more competitive internationally and enhancing global trade.

• Our research is driving the discovery of new vaccines that are transforming the future of public health.

Success through collaboration 

• VIDO-InterVac is open to academic teams and researchers from Canadian and international universities, commercial partners, research institutes and governments.

• Cutting-edge technology and facilities provide unparalleled opportunities for research.

News

• The VSTG discusses swine production - Jan 01, 2010

Current News 

Introducing InterVac

The International Vaccine Centre (InterVac) is Canada's newest lab for protecting animals and humans against emerging infectious diseases:

• The new $140 million InterVac facility addresses the international shortage of facilities for studying Containment Level 3 (CL3) pathogens using diverse animal models.

• When InterVac opens in 2011, it will be one of the largest facilities of its kind in North America.

Learn more about this cutting-edge facility through our online newsletter, Inside VIDO-InterVac. 

InterVac construction in action ....see for yourself!

• Last hour animated
• Last 24 hours animated
• Time lapse from start of construction